Mammographic surveillance in the follow up of early primary breast cancer in England: A cross-sectional survey

References 

1. Office of National Statistics . Available from: <http://www.statistics.gov.uk/CCI/nugget.asp?ID=575&Pos=&ColRank=1&Rank=374>2007;[accessed 08.05.07]
2. Office Of National Statistics . Cancer statistic registrations: registrations of cancer diagnosed in 2004, England. Series MB1 no. 35 London: National Statistics; 2006;
3. Robinson D, Bell J, Mollerh. and Salman A. A 13-year follow-up of patients with breast cancer presenting to a District General Hospital breast unit in southeast England. The Breast. 2006;15:173–180
4. Hurria A, Hudis C. Follow-up care of breast cancer survivors. Critical Reviews in Oncology/Hematology. 2003;48:89–99
   • Abstract
   • Full Text
   • Full-Text PDF (115 KB)
   • CrossRef
5. In:  Dixon MJ editors. ABC of breast diseases. 3rd ed.. Oxford: Blackwell Publishing; 2006;
6. National Institute For Clinical Excellence . National Institute for Health and Clinical Excellence website. Early breast cancer – final scope. Available from: <http://www.guidance.nice.org.uk/page.aspx?0=350117>2006;[accessed 14.01.08]
7. National Institute For Clinical Excellence . National Institute for Health and Clinical Excellence website. Advanced breast cancer – final scope. Available from: <http://www.guidance.nice.org.uk/page.aspx?0=350111>2006;[accessed 03.05.07]
8. Peppercorn J, Partridge A, Burstein HJ, Winer EP. Standards for follow-up care of patients with breast cancer. The Breast. 2005;14:500–508
9. National Institute For Clinical Excellence . Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Partial update of NICE CG 14 London: NICE; 2006;
10. National Health Service Breast Screening Programme . NHS breast screening programme: annual review 2006. Sheffield: NHSBSP; 2006;
11. British Association of Surgical Oncology . Guidelines for the management of symptomatic breast disease. The association of breast surgery @ BASO, Royal College of Surgeons of England. European Journal of Surgical Oncology. 2005;31:1–21
12. National Institute for Clinical Excellence . Improving outcomes in breast cancer: manual update. London: NICE; 2002;
13. Royal College of Radiologists . Guidance on screening and symptomatic breast imaging. 2nd ed.. London: RCR; 2003;
14. Yorkshire Cancer Network . Guidelines for the non-surgical management of breast cancer. Leeds: YCN; 2004;
15. National Institute for Clinical Excellence . Improving outcomes in breast cancer. London: NICE; 1996;
16. Department Of Health . The NHS cancer plan: a plan for investment, a plan for reform. London: Crown; 2000;
17. Dr. Foster Intelligence Good Cancer Guide . Available from: <http://www.drfoster.co.uk/localservices/objectlist.aspx?w=30>2007;[accessed 07.02.07]
18. Egger JR, Cutter GR, Carney P, Taplin SH, Barlow WE, Hendrick E, et al. Mammographers perception of women's breast cancer risk. Medical Decision Making. 2005;25:283–289
19. Denscombe M. The good research guide. 3rd ed.. Maidenhead: Open University Press; 2007;
20. Collins RF, Bekker HL, Dodwell DJ. Follow-up care of patients treated for breast cancer: a structured review. Cancer Treatment Reviews. 2004;30:19–35
    • Abstract
    • Full Text
    • Full-Text PDF (417 KB)
    • CrossRef
21. Clemons M, Danson S, Hamilton T, Goss P. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treatment Reviews. 2001;27:67–82
    • Abstract
    • Full-Text PDF (399 KB)
    • CrossRef
22. Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: national surgical adjuvant breast and bowel project protocol-06. Cancer Supplement. 2001;91(8):1679–1687
23. Nishimura S, Takahashi K, Akiyama F, Oguchi M, Tada K, Makita M, et al. Classification of ipsilateral breast tumor recurrences after breast-conserving therapy: new primary allows a good prognosis. Breast Cancer. 2005;12(2):112–117
    • MEDLINE
    • CrossRef
24. Komoike Y, Akiyama F, Iino Y, Ikeda T, Tanaka-Akashi S, Ohsumi S, et al. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer. 2005;12(2):104–111
    • MEDLINE
    • CrossRef
25. Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, et al. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer. 2005;104(3):479–490
    • MEDLINE
    • CrossRef
26. McCloskey SA, Botnick LE, Rose CM, Malcolm AW, Ozohan ML, Mena R. Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting. The Breast Journal. 2006;12(2):138–144
    • MEDLINE
    • CrossRef
27. Elder EE, Kennedy CW, Gluch L, Carmalt HL, Janu NC, Joseph MG, et al. Patterns of breast cancer relapse. European Journal of Surgical Oncology. 2006;32:922–927
28. Wapnir IL, Anderson SJ, Mamounas EP, Geyer JR, Jeong J-H, Tan-Chiu E, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. Journal of Clinical Oncology. 2006;24(13):2028–2037
29. Levi F, Randimbison L, Te V-C, La Vecchia C. Contralateral breast cancer in Vaud, Switzerland. Letter to the editor International Journal Cancer. 2001;93:612–613
30. American Society of Clinical Oncology (ASCO) . American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. Journal of Clinical Oncology. 2006;24(31):5091–5097
31. Grunfeld, E, Dhesy-Thind, S, Levine, M. Clinical practice guidelines for the care and treatment of breast cancer: 9. Follow-up after treatment for breast cancer (2005 update). Health Canada, 2005.
32. Pestalozzi BC, Luporsi-Gely EL, Jost M, Bergh J. ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Annals of Oncology. 2005;16(Suppl. 1):
33. Scottish Intercollegiate Guidelines Network . Management of breast cancer in women: a national clinical guideline. Edinburgh: SIGN; 2005;
34. National Health Service Breast Screening Programme . Clinical guidelines for breast cancer screening assessment. NHSBSP Publication 49 Sheffield: NHSBSP; 2005;
35. McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Available from: Breast Cancer Research. 2002;<http://breast-cancer-research.com/content/4/5/R11>[accessed 02.02.08]
36. Olsson P, Armelius K, Nordahl G, Lenner P, Westman G. Women with false positive screening mammograms: how do they cope?. Journal of Medical Screening. 1999;6:89–93
    • MEDLINE
37. Cardenosa G. Breast imaging companion. 2nd ed.. Philadelphia: Lippincott Williams & Wilkins; 2001;
38. National Institute for Clinical Excellence . Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Update. July 2006 London: NICE; 2006;
39. Great Britain The ionising radiation (medical exposure) regulations 2000: Elizabeth II. Statutory Instrument No. 1059 London: The Stationery Office; 2000;
40. Takeuchi H, Ueo H, TsujiI K, Tokunaga E, Baba H, Maehara Y. Prediction of survival from first recurrence of breast carcinoma in Japanese women. The Breast. 2006;15:226–231
41. De Bock GH, Van Der Hage JA, Putter H, Bonnema J, Bartelink H, Van De Velde CJ. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. European Journal of Cancer. 2006;42:351–356
42. Szelei-Stevens KA, Kuske RR, Yantoss VA, Cederbom GJ, Bolton JS, Fineberg BB. The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy. International Journal of Radiation Oncology, Biology, Physics. 2000;48(4):43–49
    • Abstract
    • Full Text
    • Full-Text PDF (569 KB)
    • CrossRef
43. Hill-Kayser CE, Harris EER, Hwang W-T, Solin LJ. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. International Journal of Radiation Oncology, Biology, Physics. 2006;66(5):1313–1319
    • Abstract
    • Full Text
    • Full-Text PDF (177 KB)
    • CrossRef
44. Soerjomataram I, Louwman WJ, Lemmens VE, De Vries E, Klokman WJ, Coebergh JW. Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972–2001. European Journal of Cancer. 2005;41:2331–2337
45. Mertens WC, Hilbert VH, MakariI-Judson G. Contralateral breast cancer: factors associated with stage and size at presentation. The Breast Journal. 2004;10(4):304–312
    • MEDLINE
    • CrossRef
46. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, Powe DG, et al. A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene. 2007;26(10):1507–1516
    • MEDLINE
    • CrossRef
47. Cassidy J, Bissett D, Spence(EDs) RAJ. Oxford handbook of oncology. 2nd ed.. Oxford: Oxford University Press; 2006;
48. Stracci F, La Rosa F, Falsettini E, Ricci E, Aristei C, Bellazza G, et al. A population survival model for breast cancer. The Breast. 2005;14:94–102
49. National Institute for Clinical Excellence . National Institute for Health and Clinical Excellence website. Early breast cancer – draft scope. Available from: <http://www.guidance.nice.org.uk/page.aspx?0=350117>2006;[accessed 14.01.08]